Cancer Diagnosis

Can Technology Advance Early Diagnosis?

It is generally recognised that early diagnosis significantly improves cancer survival rates; advances in technology are leading to achieving that desirable outcome.  The Cancer Diagnostic Technology Summit 2022 provides a platform for leading developers to showcase the current and future directions of technology in cancer diagnosis.  The Conference will explore advances in a range of diagnostic methodologies, and concerns that very early diagnosis may lead to treatment of biologically insignificant cancers.

Key Technologies

Blood biopsy

Biomarkers in breath, saliva and urine

Cell separation and DNA sequencing

AI in imaging and data mining

Participate in CDT22


Booths are still available to display promotional material, a video etc. Register here to reserve a Booth

Poster exhibits will be accepted until 10th June. Send the poster title to
Free registration for students exhibiting posters.




Organising Committee

Prof. H Thomas Aretz MD, Harvard Medical School

Dr. Michael Brand, Sensor100

Dr. Kalypso Charalambous, Imperial College

Dr. Pedro Estrela, University of Bath


Sponsored by: